[Federal Register: April 27, 2004 (Volume 69, Number 81)]
[Notices]
[Page 22810-22811]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27ap04-68]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 04129]
Improving the Effectiveness of the Diagnosis and Treatment of
Tuberculosis and Multi-Drug Resistant Tuberculosis in the Philippines;
Notice of Intent to Fund Single Eligibility Award
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
intent to fund fiscal year (FY) 2004 funds for a cooperative agreement
program to support and ensure the implementation of tuberculosis (TB)
control activities that are designed to develop, establish, and
coordinate systems and procedures to address the obstacles to achieving
control of TB and multi-drug resistant tuberculosis (MDR-TB). The
Catalog of Federal Domestic Assistance number for this program is
93.116.
B. Eligible Applicant
Assistance will be provided only to Makati Medical Center (MMC)
located in Manila, the Philippines.
The MMC is the only qualified organization that has the technical
and administrative capacity to conduct the specific set of activities
requested to support CDC TB and MDR-TB prevention and control
activities in the Philippines under this cooperative agreement because:
1. The MMC is uniquely positioned, in terms of legal authority,
ability, track record, infrastructure and credibility in the
Philippines to develop and support TB and MDR-TB control activities in
both public and non-governmental organization sites throughout the
country.
2. The MMC has already established a framework and mechanisms to
develop and implement TB and MDR-TB treatment and control activities in
the Philippines, enabling it to immediately become engaged in the
activities listed in this announcement.
3. The MMC has demonstrated its ability to coordinate and implement
TB treatment and control activities
[[Page 22811]]
including MDR-TB and TB/HIV co-infection within the country.
4. The MMC has a unique and unparalleled relationship with the
Department of Health (DOH), NTP, the Tropical Disease Foundation (TDF),
and the PhilCAT, based on a rich history of collaboration.
5. The MMC Directly Observed Treatment Short Course (DOTS) Clinic
has been in existence since February 1999, in response to the need for
public-private partnership in the management of TB patients in the
Philippines. The clinic is a collaboration of the MMC and TDF
representing the private sector, and the DOH and Barangay San Lorenzo
(BSL) representing the public sector.
6. The MMC was approved as the first pilot project worldwide to
undertake DOTS-Plus by the Green Light Committee (GLC), a subgroup of
the Scientific Working Group on Multi-Drug Resistant Tuberculosis of
the WHO. The MMC DOTS-Plus clinic is the only facility in the
Philippines providing treatment to MDR-TB patients.
7. The MMC has the ability to collect information, train staff and
advocate for policy based on the experiences learned implementing DOTS-
Plus activities.
8. The specific services that the MMC will deliver are directly
associated with, and compliment, other ongoing CDC prevention
strategies and activities in the Philippines.
C. Funding
Approximately $100,000 is available in FY 2004 to fund this award.
It is expected that the award will begin on or before June 1, 2004, and
will be made for a 12-month budget period within a project period of up
to five years. Funding estimates may change.
D. Where to Obtain Additional Information
For general comments or questions about this announcement, contact:
Technical Information Management, CDC Procurement and Grants Office,
2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
For technical questions about this program, contact: Michael
Qualls, Project Officer, Division of Tuberculosis Elimination, National
Center for HIV, STD, and TB Prevention, Centers for Disease Control and
Prevention (CDC), 1600 Clifton Road Mailstop E-10, Atlanta, Georgia
30333, Telephone: 404-639-8488, E-mail: MQualls@cdc.gov.
For budget assistance, contact: Steward Nichols, Grants Management
Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, Georgia 30341, Telephone: 770-488-2788, E-mail:
SNichols1@cdc.gov.
Dated: April 20, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-9493 Filed 4-26-04; 8:45 am]
BILLING CODE 4163-18-P